K922582

Substantially Equivalent

BARTELS CYTOMEGALOVIRUS IGG EIA

Applicant: Baxter Diagnostics, Inc.
Product code: LFZ
Advisory panel: Microbiology
Date received: 1992-05-27
Decision date: 1993-04-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.